Endothelial Dysfunction, Fibrinolytic Activity and Coagulation Activity in Patients With Atrial Fibrillation According to Type II Diabetes Mellitus Status

Recent findings in atrial fibrillation (AF) patients receiving oral anticoagulation showed that diabetes without insulin therapy has a thromboembolic risk comparable to non-diabetic patients, whereas only diabetic patients on insulin have a heightened thromboembolic risk. We explored possible pathophysiological correlates of such finding on 90 AF patients on oral anticoagulation, divided according to diabetes status (N=30 without diabetes; N=29 with diabetes on oral antidiabetic drugs; N=31 with insulin-requiring diabetes).

Source: The American Journal of Cardiology - December 8, 2019 Category: Cardiology Authors: Giuseppe Patti, Elisabetta Cerchiara, Edoardo Bressi, Barbara Giannetti, Alessia Delli Veneri, Germano Di Sciascio, Giuseppe Avvisati, Raffaele De Caterina Source Type: research